Citicoline & Antioxidants in Glaucoma

NCT06355765 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2024-04-17

No results posted yet for this study

Summary

To evaluate the long-term effects of oral citicoline, vitamins A, B, C and E, and blackcurrant therapy in patients with primary open-angle glaucoma (POAG) using optical coherence tomography (OCT), OCT angiography (OCTA) and microperimetry parameters.

Conditions

  • Glaucoma, Open-Angle

Interventions

DIETARY_SUPPLEMENT

Citicoline blackcurrant supplement

Citicoline, Vitamins A, B, C and E, and Blackcurrant

Sponsors & Collaborators

  • University of Naples

    lead OTHER

Principal Investigators

  • Luca D'Andrea, MD · Federico II University

Eligibility

Min Age
30 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-10
Primary Completion
2022-12-10
Completion
2022-12-10

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06355765 on ClinicalTrials.gov